Understanding and Treating PANS and PANDAS: A Comprehensive Approach with a Focus on Antibiotics
Managing sudden-onset neuropsychiatric conditions like Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) can be overwhelming for families. At Philadelphia Integrative Psychiatry, Dr. Danish and his team are dedicated to staying at the forefront of research and providing support for these complex conditions. While they do not currently act as primary treatment providers for PANS or PANDAS, Dr. Danish’s extensive training in these disorders allows him to collaborate effectively with regional PANS specialists. This co-management approach ensures that families have access to comprehensive care tailored to their child’s unique needs. One key area of focus in managing these disorders is the use of antibiotics, which play a pivotal role when infections are suspected triggers.
This blog delves into the mechanisms driving PANS and PANDAS symptoms, the role of immune dysregulation, and the effectiveness of various treatment approaches, with a special emphasis on antibiotic therapy.
How Immune Dysregulation Drives PANS and PANDAS Symptoms
PANS and PANDAS are believed to result from immune-mediated inflammation that impacts the brain's basal ganglia, a region critical for motor control, behavior, and cognition. Autoantibodies targeting neuronal proteins in this area disrupt normal function, leading to symptoms such as obsessive-compulsive behaviors, tics, emotional dysregulation, and eating restrictions. For example:
Autoantibodies against dopamine receptors (D1R/D2R) have been linked to altered dopamine signaling.
Elevated cytokines like interleukin-17 (IL-17) can disrupt the blood-brain barrier (BBB), allowing immune cells to infiltrate the brain and exacerbate neuroinflammation.
Emerging research also highlights the gut-brain axis's potential role in these disorders. Altered gut microbiota may contribute to systemic inflammation and immune dysregulation, suggesting that microbiome-targeted therapies could complement traditional treatments.
Antibiotics as a Cornerstone of Treatment
Antibiotics are often a first-line treatment in PANS/PANDAS when infections such as Group A Streptococcus (GAS) are suspected triggers. They not only target bacterial pathogens but may also have immunomodulatory effects that reduce neuroinflammation.
Commonly Used Antibiotics
Beta-lactams: Penicillin, amoxicillin, and amoxicillin-clavulanate (Augmentin) are highly effective against GAS. Augmentin is particularly noted for its ability to cross the BBB due to clavulanate's properties.
Cephalosporins: Cefdinir and cephalexin are effective alternatives for GAS infections or when beta-lactams are insufficient.
Macrolides: Azithromycin is frequently used for its broad-spectrum activity and anti-inflammatory properties, especially in patients intolerant to beta-lactams.
Clindamycin: This antibiotic is effective in cases where resistance or treatment failure occurs with other antibiotics.
Dosing and Duration
Initial antibiotic courses typically last 10–14 days. If significant improvement is observed, treatment-level doses may be extended for an additional 2–4 weeks.
For moderate cases, a 30-day course is often recommended, sometimes combined with anti-inflammatory agents like NSAIDs or corticosteroids.
Prophylactic antibiotics may be considered for recurrent exacerbations or severe cases but are more commonly used in PANDAS than PANS.
Effectiveness
Studies show that antibiotics can lead to symptom resolution within 14 days in approximately 50% of cases during acute episodes.
A pilot study using cefdinir at treatment doses (14mg/kg14 \mathrm{mg}/\mathrm{kg}) demonstrated significant improvements in OCD symptoms associated with PANS/PANDAS.
Potential Side Effects
While generally well-tolerated, antibiotics can cause gastrointestinal disturbances or allergic reactions. Long-term use may increase the risk of antibiotic resistance.
Complementary Treatments
In addition to antibiotics, a multi-pronged approach is often necessary:
Anti-inflammatory therapies: NSAIDs and corticosteroids can reduce neuroinflammation during acute flares.
Immunomodulatory interventions: Intravenous immunoglobulin (IVIG) and plasmapheresis aim to modulate aberrant immune responses but show mixed efficacy across studies.
Psychiatric support: Cognitive-behavioral therapy (CBT) tailored for OCD symptoms is essential. Low-dose selective serotonin reuptake inhibitors (SSRIs) may also be used cautiously.
Lifestyle modifications: Addressing sleep disturbances and incorporating dietary changes or probiotics can improve overall functioning.
Challenges in Treatment
Determining the most effective treatment for PANS/PANDAS remains challenging due to:
Variability in patient presentation and response to therapy
Lack of standardized diagnostic criteria
Limited use of biomarkers to predict treatment outcomes
These challenges underscore the importance of individualized care plans tailored to each patient's unique needs.
Getting PANS Treatment in Philly
Whether your child is experiencing sudden-onset neuropsychiatric symptoms or has been diagnosed with PANS/PANDAS, Philadelphia Integrative Psychiatry offers comprehensive evaluations and cutting-edge treatments. From medical management to advanced therapies like IVIG or biofeedback, Dr. Danish’s team collaborates closely with families to create personalized care plans that address both immediate needs and long-term well-being.
If you’re seeking expert guidance or a second opinion on managing PANS/PANDAS, we encourage you to contact our office today. Together, we can explore all available options to help your child regain their quality of life.
Learn more about PANS/PANDAS
Sources
Back to Blog
Disclaimer: This guide is for informational purposes only and not a substitute for medical advice. Any treatment—whether a supplement, medication, procedure, injection, therapy, or device—carries potential risks, especially when used in excess or by individuals with certain medical conditions or genetic predispositions. Always consult a qualified healthcare provider before starting any treatment.
